Alborz Investment Company (Holding) (VALBER)
- Ticker
- VALBER
- Industry
- Pharmaceuticals
- Market
- Tehran Stock Exchange
Line of business
Investment in shares; preparation, production, import, export and distribution of all types of raw materials and pharmaceutical products; establishing any kind of factory, institution or company for the import, manufacture, distribution and sale of any kind of raw materials and pharmaceutical products and the like; all types of domestic and foreign trade activities
Latest trading day
Date: October 25, 2026
- Closing price
- 4,160 rials
- Change on the previous close
- +2.72%
- Volume
- 136,797,312 shares
- Trade value
- 56.90 billion tomans
- Market cap
- 12,896 billion tomans
VALBER returns against the market, the dollar and gold
Up to the stock's last trade on October 25, 2026. Each row runs from the last price before the period starts to the latest price, and the stock's return is adjusted for capital raises and cash dividends. The indexes come from the Tehran Stock Exchange (TSETMC); the free-market dollar and 18k gold are daily free-market prices in tomans.
| Series | 1 month |
|---|---|
| VALBER | 10.1% |
| Bourse total index | 10.8% |
| Farabourse total index | 16.4% |
| Free-market dollar | 15.2% |
| 18k gold (per gram) | 7.5% |
Weekly, 3-month, 1-year and 5-year returns, and the comparison with the industry, the Emami gold coin, the world gold ounce and Tehran housing, are on Fundai with free sign-up.
Key figures
| Item | Value | Basis |
|---|---|---|
| Listed NAV per share | 6,832 rials | Last trade to October 25, 2026 |
| Net listed asset value | 21,180 billion tomans | Last trade to October 25, 2026 |
| Holding's shares | 31,000,000,000 | monthly report to 1405/06/31 |
| Unlisted stakes, at cost | 414 billion tomans in 7 companies | monthly report to 1405/06/31 |
| Item | Market value today | Share of portfolio | Ownership |
|---|---|---|---|
| Sobhan Pharmaceutical Group (DSOBHA) | 8,070 billion tomans | 38.1% | 56.1% |
| Pakhsh Alborz Company (PAKHSH) | 7,356 billion tomans | 34.7% | 50.6% |
| Tolid Darou Pharmaceutical Company (DTOLID) | 1,747 billion tomans | 8.2% | 47.7% |
| Alborz Bulk Pharmaceutical Raw Materials Company (DBALK) | 1,416 billion tomans | 6.7% | 44.6% |
| Etela Alborz Investment Company (ETELA) | 1,354 billion tomans | 6.4% | 58.6% |
| Sobhan Darou Company (DSOBHAN) | 488 billion tomans | 2.3% | 2.0% |
| Alborz Darou Company (DALBER) | 403 billion tomans | 1.9% | 1.4% |
| KBC Company (KEYBISI) | 166 billion tomans | 0.8% | 6.2% |
| Sobhan Oncology Pharmaceutical Company (DSANKO) | 121 billion tomans | 0.6% | 5.2% |
| Barekat Pharmaceutical Group (BAREKAT) | 34 billion tomans | 0.2% | 0.4% |
| Item | Market value today | Share of portfolio |
|---|---|---|
| Pharmaceuticals | 19,826 billion tomans | 93.6% |
| Investment companies | 1,354 billion tomans | 6.4% |